An affinity-modulating site on neuronal monoamine transport proteins

Pharmacol Toxicol. 1997 Apr;80(4):197-201. doi: 10.1111/j.1600-0773.1997.tb00396.x.

Abstract

The dissociation rates of [3H]nisoxetine, [3H]GBR 12935 and [3H]citalopram from, respectively, the rat brain noradrenaline, dopamine and 5-HT transporters were found to be markedly affected by several drugs. Sertraline strongly attenuated the rate of dissociation of [3H]nisoxetine from the noradrenaline transporter, while citalopram strongly attenuated that of [3H]citalopram from the 5-HT transporter. The effect of both drugs were stereospecific. Less potent affinity-modulating drugs were identified with regards to [3H]GBR 12935 dissociation from the dopamine transporter. All three neuronal monoamine transporters may thus have specific affinity-modulating sites which change the function of the transporters with possible implication for the reuptake of monoamines released during synaptic activity.

MeSH terms

  • 1-Naphthylamine / analogs & derivatives
  • 1-Naphthylamine / pharmacology
  • Animals
  • Binding Sites
  • Biogenic Monoamines / metabolism*
  • Cerebral Cortex / cytology
  • Cerebral Cortex / metabolism
  • Citalopram / metabolism
  • Citalopram / pharmacology
  • Corpus Striatum / cytology
  • Corpus Striatum / metabolism
  • Female
  • Fluoxetine / analogs & derivatives
  • Fluoxetine / metabolism
  • In Vitro Techniques
  • Kinetics
  • Neurons / metabolism*
  • Piperazines / metabolism
  • Rats
  • Receptors, Neurotransmitter / metabolism*
  • Sertraline
  • Stereoisomerism

Substances

  • Biogenic Monoamines
  • Piperazines
  • Receptors, Neurotransmitter
  • Fluoxetine
  • Citalopram
  • nisoxetine
  • 1-Naphthylamine
  • 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine
  • Sertraline